BD 256066 BD VERITOR PLUS ANALYZER SYSTEM

Are your Ready for SARS-CoV-2 Testing? When your patients are in need of fast, reliable SARS-CoV-2 testing, turn to the BD VeritorPlus System. Off ering lab-quality results at the point of care, in a simple-to-operate, handheld instrument. Simplify the testing process Easy operation and 1-button functionality may potentially reduce manual test processing errors Enables intuitive sample processing with prefilled, unitized tubes color-coded by reagent or assay type Achieve fast, reliable results Displays easy-to-read digital results for SARS-CoV-2 in 15 minutes Records results on secured drive Advanced particle technology enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles, helping improve test performance Adaptive read technology helps improve specificity to reduce false-positive results by compensating for background and nonspecific binding workflow efficiency Adapts easily to your workflow by offering 2 operational modes Walk away: Test device is inserted immediately into Analyzer, enabling staff to multitask while sample incubates. Analyze now: Test device is inserted after incubation time is complete, allowing batches of samples to be tested Provide result traceability Download and display LOT number, Patient/specimen ID, Operator ID and test records with BD Veritor InfoScan module Offers result-printing capabilities via USB port Clinical Performance PPA 84% (95% C.I. 67%93%) NPA 100% (95% C.I. 98100%) Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient€™s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.